ClinVar Miner

Submissions for variant NM_001271208.2(NEB):c.23372T>C (p.Met7791Thr) (rs201767727)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
EGL Genetic Diagnostics, Eurofins Clinical Diagnostics RCV000723767 SCV000203068 uncertain significance not provided 2014-01-13 criteria provided, single submitter clinical testing
GeneDx RCV000153540 SCV000513921 likely benign not specified 2016-09-29 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.
Invitae RCV001082253 SCV000763132 likely benign Nemaline myopathy 2 2019-12-31 criteria provided, single submitter clinical testing
Athena Diagnostics Inc RCV000723767 SCV001144717 likely benign not provided 2018-09-10 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV001082253 SCV001292512 uncertain significance Nemaline myopathy 2 2017-04-27 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.
CeGaT Praxis fuer Humangenetik Tuebingen RCV000723767 SCV001334535 likely benign not provided 2020-02-01 criteria provided, single submitter clinical testing
Natera, Inc. RCV001082253 SCV001456469 likely benign Nemaline myopathy 2 2020-01-11 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.